Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

IGN523

Copy Product Info
🥰Excellent

Synonyms:

Catalog No. T9901A-1914 Copy Product Info
Purity: 95%
🥰Excellent
IGN523 is an anti-CD98 antibody (hCD98, KD = 0.55 nM) that induces antibody-dependent cell-mediated cytotoxicity (ADCC). It permeabilizes lysosomal membranes and inhibits essential amino acid transport function, leading to caspase-3 and caspase-7 mediated apoptosis of tumor cells. IGN523 inhibits tumor growth in various tumor xenograft models and can be used for research on cancers such as non-small cell lung cancer (NSCLC) and acute myeloid leukemia (AML).

IGN523

Pack SizePriceUSA StockGlobal StockQuantity
1 mg$289-In Stock
5 mg$868-In Stock
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:95%
Appearance:Liquid
Color:Transparent
Contact us for more batch information

Product Introduction

Bioactivity
Description
IGN523 is an anti-CD98 antibody (hCD98, KD = 0.55 nM) that induces antibody-dependent cell-mediated cytotoxicity (ADCC). It permeabilizes lysosomal membranes and inhibits essential amino acid transport function, leading to caspase-3 and caspase-7 mediated apoptosis of tumor cells. IGN523 inhibits tumor growth in various tumor xenograft models and can be used for research on cancers such as non-small cell lung cancer (NSCLC) and acute myeloid leukemia (AML).
In vitro
IGN523 strongly induces ADCC activity in Ramos, KG-1, and OCI-AML-3 cells with EC50 values of 18.6 ng/mL, 73.8 ng/mL, and 83.3 ng/mL, respectively, without diminishing ADCC activity within IGN523 cells. Furthermore, IGN523 (2 µg/mL, 0.5-48 hours) triggers caspase-dependent apoptosis, enhances lysosomal membrane permeability, and reduces amino acid transport in these cell lines.
In vivo
IGN523 (15 mg/kg, intraperitoneal injection, weekly, administered either two or three times) is effective in inhibiting tumor growth in Ramos and Dau xenograft mouse models. Furthermore, IGN523 (15 mg/kg, intraperitoneal injection, weekly, administered two, three, or four times) suppresses tumor growth in AML and primary NSCLC xenograft mouse models.
Storage & Solubility Information
StorageStore at low temperature, -20°C for 1 year Shipping with blue ice/Shipping at ambient temperature.

Calculator

  • Dilution Calculator
  • Reconstitution Calculator

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: IGN523 in vivo | IGN523 in vitro